Latest News
Telomir Pharmaceuticals, Inc.
- Telomir raises USD 5.6m to advance Telomir-Zn into Phase I/II TNBC trial
- Telomir Raises PIPE Financing to Fund Oncology Trials
- Telomir Pharmaceuticals Raises $5.6 Million PIPE; Issues Placement Agent Warrants
- Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company
- Telomir Pharmaceuticals raises US$5.6M in PIPE for breast cancer trial
- Telomir Pharmaceuticals (TELO) Edges Higher to $1.18 as Shares Hold Above Key Support - Retail Sentiment
Headlines from the last 30 days, linking to the original publishers. See all market news →